Status:
COMPLETED
Serial CT Scans in Fractionated Stereotactic Radiotherapy
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
Maastricht University Medical Center
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aims at providing a quantitative evaluation of the accuracy of two different fixation systems, where one system is also evaluated with two different set-ups.
Detailed Description
Stereotactic conformal radiotherapy (SCRT) combines the precision of the stereotactically guided tumor localisation and the radiobiological advantages of the fractionation. This implies an highly accu...
Eligibility Criteria
Inclusion
- Clinical diagnosis of brain tumor
- Fractionated stereotactic radiotherapy
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
July 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00181350
Start Date
November 1 2003
End Date
July 1 2007
Last Update
June 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht Radiation Oncology
Heerlen, Limburg, Netherlands, 6419 PC